ADPriboDB: A database of ADP-ribosylated proteins

Case ID:

C13672

Disclosure Date:

2/1/2016

Unmet Need
Pharmaceutical companies are conducting clinical trials for PARP inhibitors to treat cancer patients. There is currently only one drug approved in this class, but there is a need for continued and improved knowledge of PARP substrates.

Technology Overview
JHU researchers created a database that curates the last 30 years of literature on ADP-ribosylation and over 5000 substrates in humans, mouse and rate as well as other organisms. The information can provide additional support and guidance to pharmaceutical companies working in this space.
Stage of Development
The database is available at:

ADPriboDB-beta.leunglab.org

Please contact JHTV for commercial use.

Direct Link:

https://jhu.technologypublisher.com/technology/25114

Inventors:

Category(s):

Technology Classifications > Computers, Electronics & Software > Databases, Technology Classifications > Research Tools, Technology Classifications > Computers, Electronics & Software, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Small Molecules,

Get custom alerts for techs in these categories/from these inventors:

Subscribe for JHTV Updates

For Information, Contact:

Mark Maloney

dmalon11@jhu.edu

410-614-0300

Save This Technology:

Bookmark this page

Download as PDF